Sentence examples for of trial data to from inspiring English sources
Ongoing safety monitoring of clinical trials of investigational treatments must operate at levels that range from the minute and detailed – namely, mathematical treatment of trial data – to the philosophical and societal – namely, ethical concerns for individuals and populations.
Civil society organisations had a long-drawn-out battles with the Indian government and Mahyco over non-disclosure of trial data to the public in the initial years and the sale of illegal Bt cotton seeds before the Indian government's clearance.
Originally designed to provide a unified standard of trial data to support submission to regulatory authorities, the principles may also be applied to other studies of human subjects.
The strength of the present analysis is its use of trial data to reduce heterogeneity in economic outcomes through the use of statistical modelling and marginal prediction.
An important factor to consider when assessing the relevance of trial data to everyday practice is the generalisability or external validity of the studies.
Models of cervical screening are increasingly used, and allow extrapolation of trial data to project the population-level health and economic impact of different screening policy.
26 One main concern of RCTs is the difficulty of applying trial data to individual patients.
The combination of different interventions could also be investigated using this methodology, although it would depend on the existence of original trial data to provide estimates of the benefit.
With the use of screening trial data to model this process of dedifferentiation and growth, it seems that the process is age-dependent, with a transition to high-grade malignancy occurring earlier in women under the age of 50.
However, practical concerns must be addressed if the efforts of clinical trial funders, journals, and secondary users of clinical trial data to promote data sharing are to succeed.
Therefore, the purpose of the current study was to conduct a secondary analysis of clinical trial data to examine whether the two drugs were comparable as assessed by patient-reported outcomes.
